⬇️ 下载 PDF
红蓝生物

🧬 抗人PD-1参考抗体

Anti-Human PD-1 Reference Antibody

货号: RB9T37015054
💡 在您使用本产品前请认真阅读说明书,这对您顺利完成实验很有帮助。
🏷️ 产品编码
RB9T37015054
🧬 中文名称
抗人PD-1参考抗体
📝 英文名称
Anti-Human PD-1 Reference Antibody
📦 形态
Liquid
🧪 纯度
>95% purity as determined by SDS-PAGE.
🔹 内毒素水平
Please contact the lab for this information.
🔬 应用
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
🧫 表达系统
Mammalian Cells
🔢 登录号
Q15116
🔹 宿主种属
Humanized
🔹 克隆性
Monoclonal
🔹 抗体亚型
IgG4-kappa
🔹 纯化方式
Protein A/G purified from cell culture supernatant.
🔹 浓度
1.65mg/ml
🔹 种属反应性
Human
🔹 靶标
Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279
🔹 背景信息
Balstilimab is a novel, fully human monoclonal immunoglobulin G4 (IgG4) designed to block PD-1 (programmed cell death protein 1) from interacting with its ligands PD-L1 and PD-L2. PD-1 is a negative regulator of immune activation that is considered a foundational target within the immuno-oncology market.
• The blockade of immune checkpoints in cancer immunotherapy., PMID:22437870
• PD-1 and PD-L1 in cancer immunotherapy: clinical implications and future considerations., PMID:30888929
• The diverse functions of the PD1 inhibitory pathway., PMID:28990585
• PD-1/PD-L1 immune checkpoint: Potential target for cancer therapy., PMID:30191996
• Immune Checkpoint Blockade in Cancer Therapy., PMID:25605845
• PD-1 expression and clinical PD-1 blockade in B-cell lymphomas., PMID:29118007
• Overcoming T cell exhaustion in infection and cancer., PMID:25797516
• Study and analysis of antitumor resistance mechanism of PD1/PD-L1 immune checkpoint blocker., PMID:32875727
• Tumor Mutational Burden and Response Rate to PD-1 Inhibition., PMID:29262275
• PD-L1., PMID:29097600
🏷️ 别名
PF-06801591, 2206792-50-7
🧴 储存缓冲液
0.01M PBS, pH 7.4.
❄️ 稳定性和储存
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
⚠️ For research use only. Not suitable for clinical or therapeutic use.